{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T12:04:20Z","timestamp":1765713860582},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,2,19]],"date-time":"2013-02-19T00:00:00Z","timestamp":1361232000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>NICE guidance on the investigation and treatment of ovarian cancer advocates that the tumour marker CA125 should be the first line investigation for women suspected of having ovarian cancer.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>An internet-based survey, of primary care doctors in the West Midlands, was conducted in order to ascertain the views of general practitioners (GPs) of NICE guidance on the use of CA125 to triage suspected ovarian cancer cancers and the impact that this may have on referral pathways.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>In total 258 GPs responded to the questionnaire. Although 219 (84.9%) responders reported awareness of the NICE guidance only 146 (56.6%) had personally read the document. The majority 187 (72.5%) of respondents anticipated that their use of CA125 would increase as a result of the new guidance. Abdominal bloating (&gt;50\u00a0years), persistent abdominal distension and the presence of an abdominal or pelvic mass\/swelling were the symptoms felt to be most associated with ovarian cancer. When questioned on the management of a woman with a raised CA125 the majority of respondents reported that a normal ultrasound scan would not stop an urgent secondary care referral if the CA125 was raised. There was no significant difference in the opinions of GPs with &lt;5\u00a0years primary care experience compared to GPs with 6+ years.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The symptoms associated with ovarian cancer are well understood by the GPs that responded however, a coordinated programme of education and training is needed for GPs on the role of CA125 in ovarian cancer, in addition to clearly defined referral pathways, in order to address a likely significant increase in suspected ovarian cancer referrals to secondary care, most of whom will not have ovarian cancer.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1472-6874-13-8","type":"journal-article","created":{"date-parts":[[2013,2,19]],"date-time":"2013-02-19T23:03:41Z","timestamp":1361315021000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Views of general practitioners on the role of CA125 in primary care to diagnose ovarian cancer"],"prefix":"10.1186","volume":"13","author":[{"given":"Esther L","family":"Moss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Moran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy M","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Stokes-Lampard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,2,19]]},"reference":[{"key":"333_CR1","doi-asserted-by":"publisher","first-page":"d2073","DOI":"10.1136\/bmj.d2073","volume":"342","author":"C Redman","year":"2011","unstructured":"Redman C, Duffy S, Bromham N, Francis K: Recognition and initial management of ovarian cancer: summary of NICE guidance. BMJ. 2011, 342: d2073-10.1136\/bmj.d2073.","journal-title":"BMJ"},{"issue":"2","key":"333_CR2","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1245\/ASO.2003.05.015","volume":"10","author":"C Miralles","year":"2003","unstructured":"Miralles C, Orea M, Espana P, Provencio M, Sanchez A, Cantos B, Cubedo R, Carcereny E, Bonilla F, Gea T: Cancer antigen 125 associated with multiple benign and malignant pathologies. Ann Surg Oncol. 2003, 10 (2): 150-154. 10.1245\/ASO.2003.05.015.","journal-title":"Ann Surg Oncol"},{"issue":"22","key":"333_CR3","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1001\/jama.2011.766","volume":"305","author":"SS Buys","year":"2011","unstructured":"Buys SS, Partridge E, Black A, Johnson CC, Lamerato L, Isaacs C, Reding DJ, Greenlee RT, Yokochi LA, Kessel B: Effect of screening on ovarian cancer mortality: the prostate, lung, colorectal and ovarian (PLCO) cancer screening randomized controlled trial. JAMA. 2011, 305 (22): 2295-2303. 10.1001\/jama.2011.766.","journal-title":"JAMA"},{"issue":"3","key":"333_CR4","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/j.1525-1438.2007.01043.x","volume":"18","author":"EL Moss","year":"2008","unstructured":"Moss EL, Hollingworth J, Holland M, Murphy DJ, Fernando I, Reynolds TM: The use and understanding of CA125 as a tumor marker for ovarian cancer: a questionnaire-based survey. Int J Gynecol Cancer. 2008, 18 (3): 439-445. 10.1111\/j.1525-1438.2007.01043.x.","journal-title":"Int J Gynecol Cancer"},{"issue":"7","key":"333_CR5","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1111\/j.1471-0528.2005.00572.x","volume":"112","author":"CR Bankhead","year":"2005","unstructured":"Bankhead CR, Kehoe ST, Austoker J: Symptoms associated with diagnosis of ovarian cancer: a systematic review. BJOG. 2005, 112 (7): 857-865. 10.1111\/j.1471-0528.2005.00572.x.","journal-title":"BJOG"},{"issue":"8","key":"333_CR6","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1111\/j.1471-0528.2008.01772.x","volume":"115","author":"CR Bankhead","year":"2008","unstructured":"Bankhead CR, Collins C, Stokes-Lampard H, Rose P, Wilson S, Clements A, Mant D, Kehoe ST, Austoker J: Identifying symptoms of ovarian cancer: a qualitative and quantitative study. BJOG. 2008, 115 (8): 1008-1014. 10.1111\/j.1471-0528.2008.01772.x.","journal-title":"BJOG"},{"issue":"22","key":"333_CR7","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1001\/jama.291.22.2705","volume":"291","author":"BA Goff","year":"2004","unstructured":"Goff BA, Mandel LS, Melancon CH, Muntz HG: Frequency of symptoms of ovarian cancer in women presenting to primary care clinics. JAMA. 2004, 291 (22): 2705-2712. 10.1001\/jama.291.22.2705.","journal-title":"JAMA"},{"issue":"5","key":"333_CR8","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1093\/fampra\/cmi044","volume":"22","author":"GD Friedman","year":"2005","unstructured":"Friedman GD, Skilling JS, Udaltsova NV, Smith LH: Early symptoms of ovarian cancer: a case-control study without recall bias. Fam Pract. 2005, 22 (5): 548-553. 10.1093\/fampra\/cmi044.","journal-title":"Fam Pract"},{"key":"333_CR9","doi-asserted-by":"publisher","first-page":"b2998","DOI":"10.1136\/bmj.b2998","volume":"339","author":"W Hamilton","year":"2009","unstructured":"Hamilton W, Peters TJ, Bankhead C, Sharp D: Risk of ovarian cancer in women with symptoms in primary care: population based case-control study. BMJ. 2009, 339: b2998-10.1136\/bmj.b2998.","journal-title":"BMJ"},{"issue":"2","key":"333_CR10","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.ygyno.2009.05.001","volume":"114","author":"G Lurie","year":"2009","unstructured":"Lurie G, Thompson PJ, McDuffie KE, Carney ME, Goodman MT: Prediagnostic symptoms of ovarian carcinoma: a case-control study. Gynecol Oncol. 2009, 114 (2): 231-236.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"333_CR11","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/cncr.22371","volume":"109","author":"BA Goff","year":"2007","unstructured":"Goff BA, Mandel LS, Drescher CW, Urban N, Gough S, Schurman KM, Patras J, Mahony BS, Andersen MR: Development of an ovarian cancer symptom index: possibilities for earlier detection. Cancer. 2007, 109 (2): 221-227. 10.1002\/cncr.22371.","journal-title":"Cancer"},{"key":"333_CR12","volume-title":"Ovarian cancer: the recognition and initial management of ovarian cancer","author":"National Institute for Health and Clinical Excellence","year":"2011","unstructured":"National Institute for Health and Clinical Excellence: Ovarian cancer: the recognition and initial management of ovarian cancer. 2011, http:\/\/www.nice.org.uk\/nicemedia\/live\/13464\/54194\/54194.pdf."},{"issue":"1","key":"333_CR13","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1093\/ajcp\/79.1.98","volume":"79","author":"SE Kabawat","year":"1983","unstructured":"Kabawat SE, Bast RC, Welch WR, Knapp RC, Colvin RB: Immunopathologic characterization of a monoclonal antibody that recognizes common surface antigens of human ovarian tumors of serous, endometrioid, and clear cell types. Am J Clin Pathol. 1983, 79 (1): 98-104.","journal-title":"Am J Clin Pathol"},{"key":"333_CR14","doi-asserted-by":"publisher","first-page":"d3022","DOI":"10.1136\/bmj.d3022","volume":"342","author":"A Olaitan","year":"2011","unstructured":"Olaitan A: NICE on ovarian cancer. Recommendations for detection in primary care are flawed. BMJ. 2011, 342: d3022-10.1136\/bmj.d3022.","journal-title":"BMJ"},{"key":"333_CR15","doi-asserted-by":"publisher","first-page":"d3023","DOI":"10.1136\/bmj.d3023","volume":"342","author":"JA Cave","year":"2011","unstructured":"Cave JA: NICE on ovarian cancer. Please include GPs in developing guidelines. BMJ. 2011, 342: d3023-10.1136\/bmj.d3023.","journal-title":"BMJ"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6874-13-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1472-6874-13-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6874-13-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6874-13-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T23:37:52Z","timestamp":1630539472000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/1472-6874-13-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,19]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["333"],"URL":"https:\/\/doi.org\/10.1186\/1472-6874-13-8","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,19]]},"assertion":[{"value":"24 January 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"8"}}